A federally funded, randomized clinical trial of 357 people receiving radiation for head and neck cancer, using mobile and sensor technology to remotely monitor patient symptoms, resulted in less severe symptoms related to both the cancer and its treatment (both general and cancer-related).

Scientists from the Radboud University Medical Center in Nijmegen, the Netherlands; the University of Sydney in Sydney, Australia; and St. Vincent's Hospital and the University of Melbourne in Melbourne, Australia, recently put together research about people being afraid that their cancer will return when they receive treatment customized just for them.

Pfizer said it prepared findings from studies of 13 kinds of cancers for the recent American Society of Clinical Oncology (ASCO) annual meeting.

Patients suffering from triple negative breast cancer, a treatment-resistant form of the disease, have a new option in pembrolizumab, a drug manufactured by Merck that was previously FDA-authorized for other malignancies.

Breast cancer patients treated with Eli Lilly’s experimental drug abemaciclib paired with the established medication fulvestrant live nearly twice as long without the disease returning or spreading, based on new Phase 3 clinical data, the Indianapolis-based pharmaceutical maker said in a release.

More than 30,000 cancer specialists attended the recent American Society of Clinical Oncology conference in Chicago, the American Cancer Society said.

Bristol-Myers Squibb presented data from its Phase II CA180-226 clinical trial evaluating Sprycel (dasatinib) in treating pediatric patients with chronic myeloid leukemia at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

AstraZenica said it presented positive results of the Phase III OlympiAD trial of Lynparza (olaparib) on patients with HER2-negative gBRCA-mutated metastatic breast cancer at the 2017 American Society of Clinical Oncology (ASCO) meeting in Chicago, and the results were also published in the New England Journal of Medicine.

The results of testing on three new medicines from AstraZeneca for bladder, ovarian and lung cancer will be announced at the June meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

The American Academy of Physicians Assistants (AAPA) and CancerLinQ are teaming up to advance research in cancer care, a release on the American Society of Clinical Oncology website said.

A recent study by researchers from the American Cancer Society indicates patients who have regular screenings since implementation of Affordable Care Act (ACA) are more likely to be diagnosed at the earliest, most treatable stage of four types of cancers, a posting on the American Society of Clinical Oncology website said.

AbbVie said 23 abstracts, including data on approved and investigational oncology medicines, have been accepted for presentations at the 53rd annual meeting of the American Society of Clinical Oncology (ASCO) on June 2-6 in Chicago.

The American Society of Clinical Oncology (ASCO) said results of a Phase III clinical trial of the targeted therapy gefitinib in patients with epidermal growth factor receptor (EGFR)-positive, stage II-IIIA non-small cell lung cancer (NSCLC) showed it was more effective in preventing recurrence after lung cancer surgery than chemotherapy.

A recent study of young adults who received at least one dose of human papillomavirus (HPV) vaccine showed a 88 percent lower rate of oral HPV infections versus those who had not received the vaccine, the American Society of Clinical Oncology (ASCO) said.

The American Society of Clinical Oncology (ASCO) said results of the Phase III BILCAP clinical trial for biliary tract cancer found that adding capecitabine to the patient treatment plan after surgery extended the survival rate by a median of 15 months.

The American Society of Clinical Oncology believes it is the right time to remind insurers and policymakers that utilization management tools be used in the right way.